| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 8.12T | 9.78T | 9.73T | 10.88T | 10.26T | 8.73T |
| Gross Profit | 2.42T | 2.82T | 2.58T | 2.69T | 2.56T | 2.20T |
| EBITDA | 1.38T | 1.44T | 1.35T | 1.34T | 1.37T | 1.32T |
| Net Income | 640.51B | 615.72B | 589.90B | 649.12B | 583.47B | 501.61B |
Balance Sheet | ||||||
| Total Assets | 14.69T | 13.28T | 12.22T | 12.50T | 13.89T | 11.85T |
| Cash, Cash Equivalents and Short-Term Investments | 1.13T | 866.24B | 1.04T | 1.18T | 1.35T | 1.34T |
| Total Debt | 1.06T | 1.21T | 1.18T | 2.21T | 3.13T | 2.40T |
| Total Liabilities | 8.14T | 7.25T | 6.36T | 7.17T | 8.53T | 7.39T |
| Stockholders Equity | 6.36T | 5.85T | 5.70T | 4.94T | 4.34T | 3.53T |
Cash Flow | ||||||
| Free Cash Flow | 1.41T | 925.39B | 571.47B | 416.46B | 290.08B | 420.18B |
| Operating Cash Flow | 1.74T | 1.17T | 956.61B | 827.04B | 729.94B | 793.13B |
| Investing Cash Flow | -293.02B | -530.10B | -131.54B | 151.06B | -1.05T | -458.84B |
| Financing Cash Flow | -1.39T | -467.68B | -1.02T | -1.14T | 202.74B | -184.84B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | $7.87B | 23.29 | 20.28% | 0.63% | 1.23% | -22.77% | |
71 Outperform | $136.28B | 32.67 | 13.65% | 0.77% | 8.28% | 21.01% | |
69 Neutral | $145.86B | 24.26 | 31.25% | 2.24% | 7.48% | 9.55% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
55 Neutral | $76.09B | 26.32 | 71.89% | 1.82% | -13.09% | -20.63% |